Search research articles
Contact Us
Filters
Showing results (71-80 of 205) with videos related to
Page
of 21
Sort By:
Scientific Reports
|
December 3, 2022
Anti-osteopontin therapy leads to improved edema and infarct size in a murine model of ischemic stroke
Daniel Spitzer, Tim Puetz, Moritz Armbrust, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
February 7, 2013
Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model
Patrick N Harter, Stephan Dützmann, Ulrich Drott, et al.
Clinical Epigenetics
|
December 11, 2024
DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastoma
Pinar Cakmak, Philipp Jurmeister, Iris Divé, et al.
Neuropathology and Applied Neurobiology
|
March 11, 2014
Tumour necrosis factor receptor superfamily member 9 (TNFRSF9) is up-regulated in reactive astrocytes in human gliomas
Anna-Eva Blank, Peter Baumgarten, Pia Zeiner, et al.
Acta Neurochirurgica
|
March 2, 2023
Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection
Nico Teske, Mariana Chiquillo-Domínguez, Benjamin Skrap, et al.
Journal of Neuro-Oncology
|
September 24, 2024
Determinants of long-term survival in patients with IDH-mutant gliomas
Sophie Katzendobler, Sebastian Niedermeyer, Jens Blobner, et al.
Blood
|
August 27, 2011
Angiopoietin-2 promotes myeloid cell infiltration in a β₂-integrin-dependent manner
Alexander Scholz, Victoria Lang, Reinhard Henschler, et al.
Scientific Reports
|
March 2, 2018
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
Dirk Walter, Patrick N Harter, Florian Battke, et al.
The Journal of Biological Chemistry
|
December 23, 2018
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells
Ines Bruns, Benedikt Sauer, Michael C Burger, et al.
Journal of Cancer Research and Clinical Oncology
|
February 4, 2021
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
Eike Steidl, Katharina Filipski, Pia S Zeiner, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 205) with videos related to
Sort By:
Page
of 21
Scientific Reports
|
December 3, 2022
Anti-osteopontin therapy leads to improved edema and infarct size in a murine model of ischemic stroke
Daniel Spitzer, Tim Puetz, Moritz Armbrust, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
February 7, 2013
Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model
Patrick N Harter, Stephan Dützmann, Ulrich Drott, et al.
Clinical Epigenetics
|
December 11, 2024
DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastoma
Pinar Cakmak, Philipp Jurmeister, Iris Divé, et al.
Neuropathology and Applied Neurobiology
|
March 11, 2014
Tumour necrosis factor receptor superfamily member 9 (TNFRSF9) is up-regulated in reactive astrocytes in human gliomas
Anna-Eva Blank, Peter Baumgarten, Pia Zeiner, et al.
Acta Neurochirurgica
|
March 2, 2023
Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection
Nico Teske, Mariana Chiquillo-Domínguez, Benjamin Skrap, et al.
Journal of Neuro-Oncology
|
September 24, 2024
Determinants of long-term survival in patients with IDH-mutant gliomas
Sophie Katzendobler, Sebastian Niedermeyer, Jens Blobner, et al.
Blood
|
August 27, 2011
Angiopoietin-2 promotes myeloid cell infiltration in a β₂-integrin-dependent manner
Alexander Scholz, Victoria Lang, Reinhard Henschler, et al.
Scientific Reports
|
March 2, 2018
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
Dirk Walter, Patrick N Harter, Florian Battke, et al.
The Journal of Biological Chemistry
|
December 23, 2018
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells
Ines Bruns, Benedikt Sauer, Michael C Burger, et al.
Journal of Cancer Research and Clinical Oncology
|
February 4, 2021
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
Eike Steidl, Katharina Filipski, Pia S Zeiner, et al.
Page
of 21